XBiotech USA (XBIT) - Yalpi foyda koeffitsiyenti

XBiotech (XBIT) kompaniyasining rasmiy ramzlari

GURU.Markets platformasidagi daromadning yalpi foyda ulushi daromadlilik dinamikasini vizuallashtiradi, bunda 0.00 ko'rsatkichi ushbu darajani belgilaydi. XBiotech Inc. klinikalarga dori-darmonlarni yetkazib berish uchun optimallashtirilgan transport yo'nalishlari orqali samaradorlikni saqlab qolmoqda. Kompaniya o'simta yallig'lanishini to'sish uchun inson antitanachlari tizimini ishlab chiqmoqda. Tabiiy genlardan foydalanish xavfsiz terapiyalarni yaratish imkonini beradi, bu esa narxlarni belgilashda ustunlikka erishish potentsialini taqdim etadi.

Yalpi marja: XBiotech USA (XBIT) 04.07.2022 - 19.11.2026 uchun

XBiotech USA (XBIT) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Fundamental baholash:XBIT - xbiotech.com
XBiotech Inc tomonidan chiqariladigan mahsulotlar

Yalpi foyda marjasi umumiy tushumdan bevosita ishlab chiqarish xarajatlarini chegirib tashlagandan keyin qolgan foyda ulushini aniqlash orqali operatsion samaradorlikni o'lchaydi. Yalpi savdo marjasining tahlili XBiotech Inc. innovatsion antitelalari monetizatsiya qilish salohiyatini baholash imkonini beradi, bunda ishlab chiqarishning yuqori daromadliligi kelgusi II bosqich klinik ma'lumotlarining e'lon qilinishining tijorat muvaffaqiyatini tasdiqlovchi asosiy ko'rsatkich bo'lib xizmat qiladi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik